Alfacalcidol manufacturers and suppliers

Alfacalcidol suppliers

Properties

Melting point:: 134-136°C

Boiling point:: 531.5±50.0 °C(Predicted)

Density: 1.01±0.1 g/cm3(Predicted)

storage temp.: −20°C

solubility: Practically insoluble in water, freely soluble in ethanol (96 per cent), soluble in fatty oils.

pka: 14.43±0.40(Predicted)

form: White crystalline solid

color: White to Almost white

λmax: 264nm(Diethyl ether)(lit.)

Merck: 14,4819

Stability:: Light Sensitive

InChIKey: OFHCOWSQAMBJIW-GITLSTMWSA-N

SMILES: [C@@H]1(O)CC(=C/C=C2\CCC[C@@]3(C)[C@@]\2([H])CC[C@@H]3[C@H](C)CCCC(C)C)C(=C)[C@H](O)C1

Safety Information

Symbol(GHS): GHS06

Signal word: Danger

Hazard statements: H300

Precautionary statements: P301+P310+P330

Hazard Codes: T+,Xi

Risk Statements: 26/27/28-36/37/38

Safety Statements: 28-36/37-45-36-26

RIDADR: UN 2811 6.1/PG 1

WGK Germany: 3

RTECS: VS2851000

F: 8-10

HazardClass: 6.1(a)

PackingGroup: I

HS Code: 29361000

Use

Using Alfacalcidol and magnesium formulation (magnesium oxide, magnesium carbonate, etc.) sometimes causes hypermagnesemia. Using Alfacalcidol and Cardiac preparations may cause cardiac arrhythmia. Using Alfacalcidol and vitamin D and its derivatives (calcitriol) , it is possible to cause hypercalcemia. Using Alfacalcidol and calcium , Thiazide diuretics, digitalis drugs , can cause hypercalcemia. And barbiturates, anti-seizure drugs may reduce the efficacy of the drug. Gastrointestinal absorption inhibitors can reduce the absorption of the drug. Combination with large doseas of Phosphorus compounds, can induce hyperphosphatemia. When Alfacalcidol and calcium preparations (calcium lactate, calcium carbonate, etc.) are used together, there may be hypercalcemia.

You can find Alfacalcidol suppliers, manufacturers, and distributors from countries such as China, United States and the India here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.